Moreover, by inhibiting nitric oxide (NO) synthase expression, vitamin D reduces the production of NO, a key endogenous mediator in headaches, such as migraine [70] and tension-type headaches [71], deficient levels of VDBP in MOH patients can be associated with a decreased level of vitamin D, which can be one of the mechanisms of chronic headache development. Here, GC is linked to headache disorder.